CSL has priced US$1.5 billion of corporate bonds in the United States, turning to offshore debt markets to refinance its ...

An Australian company has taken one of the country's top design honours for a machine built to solve one of healthcare's most stubborn cleaning problems.

An experimental treatment being developed by Syntara improved movement in people at high risk of developing Parkinson's disease, and the benefit held for three months after treatment stopped, ...

Seven leading Chinese medical societies have jointly published an expert consensus naming Technegas the preferred ventilation agent for lung imaging in pulmonary embolism, handing the Sydney ...

Perth-based company PYC Therapeutics will take early human data on its polycystic kidney disease drug to the American Society of Nephrology conference in Denver on 22 October.

Australians living with wet age-related macular degeneration may soon be able to replace regular eye injections with a ...

Latest News; Young NZ cancer patients to get funded medicines no ma ...

Australians with moderate to severe eczema whose condition isn't controlled by steroid creams can now get a subsidised alternative. Tacrolimus ointment is now on the Pharmaceutical Benefits Scheme.